SK279615B6 - Alkaloidy z mappia foetida, spôsob ich výroby, ich - Google Patents

Alkaloidy z mappia foetida, spôsob ich výroby, ich Download PDF

Info

Publication number
SK279615B6
SK279615B6 SK834-94A SK83494A SK279615B6 SK 279615 B6 SK279615 B6 SK 279615B6 SK 83494 A SK83494 A SK 83494A SK 279615 B6 SK279615 B6 SK 279615B6
Authority
SK
Slovakia
Prior art keywords
alkaloids
water
foetidine
methanol
preparation
Prior art date
Application number
SK834-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK83494A3 (en
Inventor
Ezio Bombardelli
Giuseppe Mustich
Luisella Verotta
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of SK83494A3 publication Critical patent/SK83494A3/sk
Publication of SK279615B6 publication Critical patent/SK279615B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00—Alkaloids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK834-94A 1994-05-30 1994-07-12 Alkaloidy z mappia foetida, spôsob ich výroby, ich SK279615B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941112A IT1269862B (it) 1994-05-30 1994-05-30 Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono

Publications (2)

Publication Number Publication Date
SK83494A3 SK83494A3 (en) 1995-12-06
SK279615B6 true SK279615B6 (sk) 1999-01-11

Family

ID=11369016

Family Applications (1)

Application Number Title Priority Date Filing Date
SK834-94A SK279615B6 (sk) 1994-05-30 1994-07-12 Alkaloidy z mappia foetida, spôsob ich výroby, ich

Country Status (20)

Country Link
US (1) US5525609A (el)
EP (1) EP0685481B1 (el)
JP (1) JP3615240B2 (el)
KR (1) KR0149723B1 (el)
CN (1) CN1052233C (el)
AT (1) ATE159527T1 (el)
CA (1) CA2127763C (el)
CZ (1) CZ290320B6 (el)
DE (2) DE685481T1 (el)
DK (1) DK0685481T3 (el)
ES (1) ES2081783T3 (el)
FI (1) FI106202B (el)
GR (2) GR960300006T1 (el)
HK (1) HK1003833A1 (el)
HU (1) HU216844B (el)
IT (1) IT1269862B (el)
NO (1) NO179640C (el)
PL (1) PL177042B1 (el)
RU (1) RU2123005C1 (el)
SK (1) SK279615B6 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
WO1996011005A2 (en) * 1994-10-06 1996-04-18 Atlas Leon T Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
IT1283635B1 (it) * 1996-05-10 1998-04-23 Indena Spa Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
WO2003103610A2 (en) * 2002-03-01 2003-12-18 University Of Pittsburgh Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
US6893668B2 (en) * 2003-03-31 2005-05-17 Council Of Scientific And Industrial Research Process for isolation of anticancer agent camptothecin from Nothapodytes foetida
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
CN103181272A (zh) * 2011-12-28 2013-07-03 广东神农衍生物科技有限公司 一种药用原材料臭马比木的人工种植方法
WO2015010293A1 (zh) * 2013-07-24 2015-01-29 Zhang Yuanjin 抗癌药物组合物及其制备方法和用途
CN105053041A (zh) * 2015-08-11 2015-11-18 长沙秋点兵信息科技有限公司 一种用于农作物的杀虫剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6461482A (en) * 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
DK0540099T3 (da) * 1991-10-29 1996-06-17 Glaxo Wellcome Inc Vandopløselige camptothecinderivater
EP0556585A3 (en) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5352789A (en) * 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds

Also Published As

Publication number Publication date
SK83494A3 (en) 1995-12-06
DE69406430D1 (de) 1997-11-27
NO179640C (no) 1996-11-20
PL304577A1 (en) 1995-12-11
HK1003833A1 (en) 1998-11-06
JPH07330772A (ja) 1995-12-19
RU94026100A (ru) 1996-05-27
EP0685481A3 (en) 1996-03-06
CN1121075A (zh) 1996-04-24
ES2081783T3 (es) 1997-12-16
DK0685481T3 (da) 1998-05-25
IT1269862B (it) 1997-04-15
PL177042B1 (pl) 1999-09-30
CZ171894A3 (en) 1995-12-13
KR950032253A (ko) 1995-12-20
FI943294A0 (fi) 1994-07-11
HU216844B (hu) 1999-09-28
EP0685481A2 (en) 1995-12-06
CA2127763A1 (en) 1995-12-01
EP0685481B1 (en) 1997-10-22
RU2123005C1 (ru) 1998-12-10
HU9402089D0 (en) 1994-09-28
CN1052233C (zh) 2000-05-10
KR0149723B1 (ko) 1998-08-17
NO942633L (no) 1995-12-01
FI943294A (fi) 1995-12-01
GR3025120T3 (en) 1998-01-30
CA2127763C (en) 1997-02-25
JP3615240B2 (ja) 2005-02-02
DE69406430T2 (de) 1998-02-26
FI106202B (fi) 2000-12-15
US5525609A (en) 1996-06-11
ES2081783T1 (es) 1996-03-16
HUT71510A (en) 1995-12-28
GR960300006T1 (en) 1996-02-29
NO942633D0 (no) 1994-07-13
ITMI941112A1 (it) 1995-11-30
DE685481T1 (de) 1996-10-10
CZ290320B6 (cs) 2002-07-17
ITMI941112A0 (it) 1994-05-30
NO179640B (no) 1996-08-12
ATE159527T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
JP2009280610A (ja) 腫瘍／癌細胞の増殖の抑制活性を有するガンボージ樹脂から単離した化合物及びその化合物を含む薬学的組成物
US8299125B2 (en) Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
CN112479887B (zh) 马齿苋中一种酯类化合物及其提取分离方法和应用
SK279615B6 (sk) Alkaloidy z mappia foetida, spôsob ich výroby, ich
CN110343116B (zh) 一种野菊花提取物及其制备方法和在制备治疗鼻咽癌药物中的应用
CN103627772B (zh) 一种雷公藤内酯醇衍生物的制备方法及其产物和应用
KR0169536B1 (ko) 신규한 인삼 사포닌, 그의 제조방법 및 이를 유효성분으로 하는 항종양제
WO2018153310A1 (zh) 一种环烯醚萜类化合物及其制备方法和应用
KR980008225A (ko) 데커시놀 안젤레이트를 유효성분으로 하는 항암제
CN107674054B (zh) 一类新骨架杂萜化合物，其制备方法、药物组合物和抗肿瘤应用
CN106810551A (zh) 两种新碳架生物碱化合物及其提取分离方法
Chanal et al. Absorption and elimination of (14 C) hesperidin methylchalcone in the rat
CN109438300B (zh) 一种酚类化合物及其制备方法
CN107522764B (zh) 一种抗抑郁化合物
CN113185528B (zh) 选择性抗破骨细胞生物碱14-hydroxygelsenicine的药物应用
CN115677471B (zh) 玫瑰烷型二萜类化合物及制备、药物组合物和抗肿瘤应用
CN114539217B (zh) 一种二聚异喹啉生物碱化合物及其制备和用途
CN116693591B (zh) 一个乌苏烷三萜咖啡酸酯化合物的制备与抗肿瘤应用
CN115536532A (zh) 巴豆烷型二萜类化合物及其制备方法、药物组合物和应用
CN114591282A (zh) 从香青兰中分离得到的一个吡喃酮化合物及其制备方法与用途
CN114409670A (zh) 具有抗肿瘤活性苦木素类化合物及其制备方法与应用
JP2005314236A (ja) 新規クアシノイド系化合物及びそれらの用途
CN114642659A (zh) 香青兰中一个咖啡酸衍生物的制备方法及其用途
JPH01290627A (ja) 抗腫瘍剤
JPH0592990A (ja) カルデノライド誘導体